P&G/Gillette
This article was originally published in The Rose Sheet
Executive Summary
Innovation benefits stemming from the combination of Gillette and Procter & Gamble will come more quickly than with P&G's acquisitions of Clairol and Wella, Chairman and CEO AG Lafley states during a presentation at a Consumer Analyst Group of New York conference Feb. 24 in Scottsdale, Ariz. In response to questions from analysts regarding slower than anticipated hair color innovation sharing, Lafley notes the two earlier acquisitions faced unique challenges, including the lack of a full product pipeline at Clairol and integration obstacles with Wella due to "idiosyncracies" in German law. Gillette is an innovation-driven company with a full product pipeline, Lafley says. Initial innovation sharing opportunities include women's hair removal, men's grooming and powered products, he adds...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.